Results 91 to 100 of about 21,287 (236)

End-Stage Kidney Disease in Patients With Autosomal Dominant Polycystic Kidney Disease: A 12-Year Study Based on the Canadian Organ Replacement Registry

open access: yesCanadian Journal of Kidney Health and Disease, 2018
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, with afflicted patients often progressing to end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT).
Brandon Budhram   +9 more
doaj   +1 more source

Ouabain enhances ADPKD cell apoptosis via the intrinsic pathway [PDF]

open access: yes, 2016
Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly influenced by factors circulating in blood. We have shown that the hormone ouabain enhances several characteristics of the ADPKD cystic phenotype, including the rate of cell ...
Gustavo Blanco   +3 more
core   +1 more source

Extrarenal manifestations of ADPKD

open access: yesKidney International, 1997
A 47-year-old woman was evaluated in the Nephrology Clinic at New England Medical Center for autosomal dominant polycystic kidney disease (ADPKD). She had undergone abdominal and pelvic noncontrast computed tomographic scans for the evaluation of dyspareunia and stress incontinence.
openaire   +2 more sources

Severe parental phenotype associates with hypertension in children with ADPKD.

open access: yes, 2023
Early detection of hypertension in children with autosomal polycystic kidney disease (ADPKD) may be beneficial, but screening children at risk of ADPKD remains controversial.
Nathalie Demoulin   +15 more
core   +1 more source

Extrarenale Manifestationen der autosomal dominanten polyzystischen Nierenerkrankung (ADPKD) [PDF]

open access: yes, 2023
Die autosomal dominante polyzystische Nierenerkrankung (ADPKD) ist eine chronisch fortschreitende Systemerkrankung, die bei mehr als 75 % der Betroffenen zu einem Nierenversagen als zentraler Manifestation führt.
Arjune, Sita
core  

Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2017
Hypertension is a common early finding in autosomal dominant polycystic kidney disease (ADPKD). Improvements in screening and diagnosis of ADPKD have allowed earlier diagnosis, later onset of end-stage renal disease, and better survival.
Imed Helal   +3 more
doaj   +1 more source

Polycystin 2: a calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD

open access: yesCellular Signalling, 2019
Polycystin 2 (PC2) is one of two main protein types responsible for the underlying etiology of autosomal dominant polycystic kidney disease (ADPKD), the most prevalent monogenic renal disease in the world.
Allison L. Brill, B. Ehrlich
semanticscholar   +1 more source

The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition

open access: yesPLoS ONE, 2018
Background and objectives ADPKD is erroneously perceived as a not rare condition, which is mainly due to the repeated citation of a mistaken interpretation of old epidemiological data, as reported in the Dalgaard's work (1957).
Andrea Solazzo   +11 more
semanticscholar   +1 more source

Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles

open access: yesEBioMedicine, 2019
Background Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common causes of end-stage renal failure, caused by mutations in PKD1 or PKD2 genes. Tolvaptan, the only drug approved for ADPKD treatment, results in serious side-effects,
Tareq B. Malas   +8 more
semanticscholar   +1 more source

SO029IDENTIFYING THE CULPRIT GENE IN 400 GENETICALLY UNRESOLVED AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY OR LIVER DISEASE (ADPKD/ADPLD) PEDIGREES

open access: yes, 2017
INTRODUCTION AND AIMS: In 7 to 10% of ADPKD patients no mutation of the PKD1 and PKD2 genes is identified. The recent description of GANAB, encoding the α subunit of the glucosidase II, where mutations impair polycystin trafficking, indicate further ...
Yannick Le Meur   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy